| 1 |
35179349 | Depleting Tumor Infiltrating B Cells to Boost Antitumor Immunity with Tumor Immune-Microenvironment Reshaped Hybrid Nanocage. | 2022 Mar 22 |
1 |
| 2 |
32911375 | Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia. | 2020 Oct |
1 |
| 3 |
30938714 | Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL. | 2019 Apr 2 |
1 |
| 4 |
29285806 | Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies. | 2018 Apr |
1 |
| 5 |
30149317 | Dynamic changes in HLA-DR expression during short-term and long-term ibrutinib treatment in patients with chronic lymphocytic leukemia. | 2018 Sep |
1 |